ADRA2B

Adrenoceptor Alpha 2B

Gene Information Card

Symbol ADRA2B
Full Name Adrenoceptor Alpha 2B
Gene Type protein-coding
Chromosomal Location 2q11.2
NCBI Gene ID 151 ncbi.nlm.nih.gov/gene/151
Ensembl ID ENSG00000181222
UniProt ID P18089
OMIM ID 104260
HGNC ID 282
Aliases ADRA2L1, ADRA2RL1, ALPHA2BAR

Description

The ADRA2B gene encodes the alpha-2B adrenergic receptor, a member of the G protein-coupled receptor family. This receptor mediates the effects of catecholamines such as norepinephrine and epinephrine, primarily through inhibition of adenylyl cyclase via Gi/Go proteins. It is involved in vasoconstriction, regulation of blood pressure, and modulation of neurotransmitter release. The gene is located on chromosome 2q11.2 and spans approximately 20 kb, containing a single coding exon.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hypertension ADRA2B variants may alter receptor function, affecting vascular tone and blood pressure regulation. PMID: 10618347
Obesity Polymorphisms in ADRA2B have been associated with altered metabolic rate and fat distribution. PMID: 15181060
Attention-Deficit/Hyperactivity Disorder (ADHD) ADRA2B variants may influence noradrenergic signaling in prefrontal cortex, affecting attention and impulse control. PMID: 18470922

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose tissue 12.5 Medium
Brain 8.3 Low
Heart 6.7 Low
Kidney 4.2 Low
Liver 2.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
HEK293 15.0 High expression in transfected cells
SH-SY5Y 9.8 Endogenous expression
HepG2 3.4 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs1800544 (Glu12Glu) synonymous 0.35 (global) No known functional effect
rs2229169 (Ala178Thr) missense 0.02 (global) May alter receptor internalization
rs1042718 (Gly16Arg) missense 0.12 (global) Associated with altered agonist response
Mutation functional classification

Loss of Function (LOF)

No well-characterized loss-of-function mutations reported in ADRA2B.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported in ADRA2B.

Dominant Negative (DN)

No dominant-negative mutations reported for ADRA2B.

Gene Ontology (GO)

• G protein-coupled receptor activity (GO:0004930) • alpha2-adrenergic receptor activity (GO:0004938)
• adenylate cyclase inhibiting G protein-coupled receptor signaling pathway (GO:0007193) • norepinephrine binding (GO:0051380)
• plasma membrane (GO:0005886)

Pathways

Adrenergic signaling in cardiomyocytes (KEGG: hsa04261)
cAMP signaling pathway (KEGG: hsa04024)
Neuroactive ligand-receptor interaction (KEGG: hsa04080)

Protein Summary

The alpha-2B adrenergic receptor is a 450-amino acid protein with seven transmembrane domains, typical of G protein-coupled receptors. It is expressed in various tissues including brain, adipose, and vascular smooth muscle. Upon agonist binding, the receptor couples to Gi/Go proteins, inhibiting adenylyl cyclase and reducing cAMP levels. This receptor plays a key role in vasoconstriction, blood pressure regulation, and modulation of neurotransmitter release. Structural studies have identified key residues for ligand binding and G protein coupling.

Related Products

Product name Cat.No. Species Gene ID
ADRA2B Knockout HEK293 Cell Line EDJ-KQ1834 Human 151 Details Get a Quote
ADRA2B Knockout HeLa Cell Line EDJ-KQ52568 Human 151 Details Get a Quote
ADRA2B Knockout A-549 Cell Line EDJ-KQ61046 Human 151 Details Get a Quote
ADRA2B Knockout HCT 116 Cell Line EDJ-KQ69525 Human 151 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: